Yeah,, been here and heard that! Koos doesn't care one bit about Share-holders!
We were told he "heard" shareholders a couple weeks ago...
patientgal
Wednesday, July 17, 2013 6:23:42 PM
Re: None
Post # of 88215
Before I proceed, I must address something that was posed earlier. I was on the road and did not catch who it was from, but I distinctly remember the question being posed...
I do not work for a company similar to BMSN . My job involves ensuring certain regulations set forth by the FDA for pharma are maintained. My job requires me to know the pharma business upside and down--what's coming, what's going, who is hiring, who is firing, why they are hiring and firing. If a regulation changes, I am there to see that it is followed. Etc., etc., etc...
Dr. Ichim, thank you again for the most amazing conversation. Though my faith in you and what you do has not once waned, our conversation has made me giddy from the reiteration of what you represent, in your own words. Thank you!
OK, as I have maintained for several weeks now, Regen are still conducting Q&A with the FDA. This Q&A should be considered "business as usual". There are no issues with safety--this has been determined. But, as I have said before, the FDA require some data and insight on certain aspects of trials. This information cannot be released due privacy issues as well as, well, proprietary matters. Dr. Ichim is confident that approval is very much near and trials subsequently taking place as soon as possible.
During our conversation I expressed to Dr. Ichim (who is, for the most part, until today, unfamiliar with these boards, by the way) just how significant a PR or a posting by him would be as to ensure that the fears of his investors are put to rest. Dr. Ichim has assured me that he will be speaking with David Koos today and will advise him as to the importance of such information.
That said, he did grant me permission to state, emphatically, that he is confident that this Q&A with the FDA is nearing its end and that they will be initiating trials very soon.
We spoke of the science (I won't bore you). But, I will reiterate, I feel that those of you that have shorted yourself for want of a quick return had better jump back on board lest you find yourself swimming for dear life behind this boat only to see us sail away in the sunset.
Take it for what it's worth--if I had two lives to invest with, I would invest exactly the same as I have done with this company, MEDS & ENTB. This IS the wave of the future.
Ahhhhh! That felt good!
We were told he "heard" shareholders a couple weeks ago...
patientgal
Wednesday, July 17, 2013 6:23:42 PM
Re: None
Post # of 88215
Before I proceed, I must address something that was posed earlier. I was on the road and did not catch who it was from, but I distinctly remember the question being posed...
I do not work for a company similar to BMSN . My job involves ensuring certain regulations set forth by the FDA for pharma are maintained. My job requires me to know the pharma business upside and down--what's coming, what's going, who is hiring, who is firing, why they are hiring and firing. If a regulation changes, I am there to see that it is followed. Etc., etc., etc...
Dr. Ichim, thank you again for the most amazing conversation. Though my faith in you and what you do has not once waned, our conversation has made me giddy from the reiteration of what you represent, in your own words. Thank you!
OK, as I have maintained for several weeks now, Regen are still conducting Q&A with the FDA. This Q&A should be considered "business as usual". There are no issues with safety--this has been determined. But, as I have said before, the FDA require some data and insight on certain aspects of trials. This information cannot be released due privacy issues as well as, well, proprietary matters. Dr. Ichim is confident that approval is very much near and trials subsequently taking place as soon as possible.
During our conversation I expressed to Dr. Ichim (who is, for the most part, until today, unfamiliar with these boards, by the way) just how significant a PR or a posting by him would be as to ensure that the fears of his investors are put to rest. Dr. Ichim has assured me that he will be speaking with David Koos today and will advise him as to the importance of such information.
That said, he did grant me permission to state, emphatically, that he is confident that this Q&A with the FDA is nearing its end and that they will be initiating trials very soon.
We spoke of the science (I won't bore you). But, I will reiterate, I feel that those of you that have shorted yourself for want of a quick return had better jump back on board lest you find yourself swimming for dear life behind this boat only to see us sail away in the sunset.
Take it for what it's worth--if I had two lives to invest with, I would invest exactly the same as I have done with this company, MEDS & ENTB. This IS the wave of the future.
Ahhhhh! That felt good!
